Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 20.65
-0.25 (-1.20%)
Jul 24, 2026, 5:00 PM CET
Celon Pharma Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -58.97 | -39.37 | -15.09 | 21.5 | 11.94 |
Depreciation & Amortization | 46.28 | 51.86 | 41.34 | 30.88 | 20.62 |
Stock-Based Compensation | 0 | 1.56 | - | - | - |
Other Adjustments | 46.53 | -13.02 | 5.07 | 13.12 | 0.19 |
Change in Receivables | -6.79 | -1.64 | 13.24 | 3.74 | 5.65 |
Changes in Inventories | 4.07 | -3.77 | 6.38 | 0.3 | -6.46 |
Changes in Accounts Payable | -2.03 | 8.47 | -10.17 | 13.18 | -1.58 |
Changes in Other Operating Activities | -5.24 | -15.44 | 3.17 | -11.82 | -24.12 |
Operating Cash Flow | 43.36 | -23.75 | 43.95 | 70.9 | -5.05 |
Operating Cash Flow Growth | - | - | -38.01% | - | - |
Capital Expenditures | -54.44 | -22.79 | -41.35 | 99.16 | 64.95 |
Sale of Property, Plant & Equipment | 0.15 | 0.68 | 0.17 | 0.63 | 0.81 |
Purchases of Investments | 0 | -30 | -79.87 | 0.35 | 5.56 |
Proceeds from Sale of Investments | 49.38 | 70 | 0 | 0.35 | 1.97 |
Other Investing Activities | -16.72 | -25.38 | 0 | 0 | 0 |
Investing Cash Flow | -21.63 | -7.49 | -121.05 | -98.53 | -67.74 |
Long-Term Debt Issued | 1.35 | 1.53 | 0 | 12.84 | 0 |
Long-Term Debt Repaid | -9.7 | -22.44 | -17.64 | 3.85 | 1.15 |
Net Long-Term Debt Issued (Repaid) | -8.35 | -20.91 | -17.64 | 16.68 | 1.15 |
Issuance of Common Stock | 0 | 40.51 | 216 | 0 | 0 |
Net Common Stock Issued (Repurchased) | 0 | 40.51 | 216 | 0 | 0 |
Common Dividends Paid | 0 | -4.09 | -3.15 | 3.6 | 7.2 |
Other Financing Activities | -1.41 | -2.19 | -14.3 | 0.48 | 0.17 |
Financing Cash Flow | -9.76 | 13.32 | 180.91 | 4.91 | -8.52 |
Net Cash Flow | -7.54 | -5.51 | 43.98 | -22.71 | -81.31 |
Free Cash Flow | -11.08 | -46.54 | 2.6 | 170.07 | 59.9 |
Free Cash Flow Growth | - | - | -98.47% | 183.91% | -37.41% |
FCF Margin | - | - | - | - | 58.58% |
Free Cash Flow Per Share | -0.21 | -0.86 | 0.06 | 3.78 | 1.33 |
Levered Free Cash Flow | -99.07 | -37.02 | -29.87 | 147.47 | 66.5 |
Unlevered Free Cash Flow | -56.63 | -13.12 | -8.67 | 131.1 | 63.96 |